Condition: Persistent Atrial Fibrillation · Paroxysmal Atrial Fibrillation · Sponsor: Vivek Reddy
This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of care.
This description comes directly from the study's public registry record.
Devin Chamberlain · (646) 984-1049 · devin.chamberlain@mountsinai.org
Betsy Ellsworth, MSN, ANP · Betsy.ellsworth@mountsinai.org
Always discuss trial participation with your own doctor first.
| The Mount Sinai Hospital | New York, New York, United States | Recruiting |
| Valley Health System | Winchester, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07535268